Edition:
India

Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

156.34USD
21 Feb 2018
Change (% chg)

-- (--)
Prev Close
$156.34
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
84,424
52-wk High
$170.27
52-wk Low
$95.21

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.49 December 22 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.33 2.33 2.33 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 2 25.77 27.40 24.15 --
Quarter Ending Jun-18 2 37.96 38.43 37.50 --
Year Ending Dec-18 6 165.79 188.90 153.48 204.79
Year Ending Dec-19 5 202.39 238.70 174.10 259.26
Earnings (per share)
Quarter Ending Mar-18 3 0.49 1.33 0.02 --
Quarter Ending Jun-18 3 0.51 0.55 0.43 --
Year Ending Dec-18 6 2.60 4.57 1.96 4.17
Year Ending Dec-19 4 3.96 6.84 2.75 6.16
LT Growth Rate (%) 2 27.50 30.00 25.00 48.14

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 47.82 50.46 2.65 5.54
Quarter Ending Sep-17 30.91 33.38 2.46 7.96
Quarter Ending Jun-17 24.07 28.00 3.93 16.32
Quarter Ending Mar-17 31.24 29.27 1.97 6.31
Quarter Ending Dec-16 40.33 38.19 2.15 5.33

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 25.77 27.02 27.02 27.02 --
Quarter Ending Jun-18 37.96 39.36 39.36 39.36 --
Year Ending Dec-18 165.79 166.88 166.61 166.61 204.79
Year Ending Dec-19 202.39 198.31 198.23 200.63 259.26

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 1 0 1
Quarter Ending Jun-18 0 1 0 1
Year Ending Dec-18 0 1 1 1
Year Ending Dec-19 1 0 2 0
Earnings